Publications

Detailed Information

Controlled release of nerve growth factor from fibrin gel

DC Field Value Language
dc.contributor.authorBhang, Suk Ho-
dc.contributor.authorJeon, Oju-
dc.contributor.authorChoi, Cha Yong-
dc.contributor.authorKim Kwon, Yun Hee-
dc.contributor.authorKim, Byung-Soo-
dc.date.accessioned2024-06-13T02:20:35Z-
dc.date.available2024-06-13T02:20:35Z-
dc.date.created2018-06-20-
dc.date.created2018-06-20-
dc.date.issued2007-03-
dc.identifier.citationJournal of Biomedical Materials Research - Part A, Vol.80A No.4, pp.998-1002-
dc.identifier.issn1549-3296-
dc.identifier.urihttps://hdl.handle.net/10371/204391-
dc.description.abstractNerve growth factor (NGF) is known to promote the axonal regeneration in injured nerve system. Delivery of NGF for a long period in a controlled manner may enhance the regeneration efficacy. In this study, we investigated whether NGF can be released from fibrin gel for a long period in a controlled manner. We also investigated whether sustained delivery of NGF using fibrin gel can enhance the efficacy of NGF in vitro. The addition of heparin to fibrin gel decreased the rate of NGF release from the fibrin gel. As the concentrations of thrombin and fibrinogen in fibrin gel increased, the NGF release rate decreased significantly, and the initial release burst decreased. NGF was released for up to 14 days in vitro. The bioactivity of NGF released from fibrin gel was assessed by morphological changes of pheochromocytoma (PC12) cells cultured in the presence of NGF-containing fibrin gel. NGF released from fibrin gel exhibited significantly higher degrees of PC12 cell viability and differentiation than NGF added in a free form daily into the culture medium. This study demonstrates that fibrin gel can release NGF in a sustained, controlled manner and in a bioactive form. (c) 2006 Wiley Periodicals, Inc.-
dc.language영어-
dc.publisherJohn Wiley & Sons Inc.-
dc.titleControlled release of nerve growth factor from fibrin gel-
dc.typeArticle-
dc.identifier.doi10.1002/jbm.a.31050-
dc.citation.journaltitleJournal of Biomedical Materials Research - Part A-
dc.identifier.wosid000244429600024-
dc.identifier.scopusid2-s2.0-33847199321-
dc.citation.endpage1002-
dc.citation.number4-
dc.citation.startpage998-
dc.citation.volume80A-
dc.description.isOpenAccessN-
dc.contributor.affiliatedAuthorChoi, Cha Yong-
dc.contributor.affiliatedAuthorKim, Byung-Soo-
dc.type.docTypeArticle-
dc.description.journalClass1-
dc.subject.keywordPlusHEPARIN-
dc.subject.keywordPlusMATRIX-
dc.subject.keywordPlusPROTEOGLYCANS-
dc.subject.keywordPlusCELLS-
dc.subject.keywordAuthornerve growth factor-
dc.subject.keywordAuthorcontrolled release-
dc.subject.keywordAuthorfibrin gel-
dc.subject.keywordAuthorpheochromocytoma cell-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Related Researcher

  • College of Engineering
  • School of Chemical and Biological Engineering
Research Area biomaterials, nanomedicine, regenerative medicine

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share